These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2574621)

  • 21. 192 IgG-saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat.
    Book AA; Wiley RG; Schweitzer JB
    J Neuropathol Exp Neurol; 1994 Jan; 53(1):95-102. PubMed ID: 8301325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of suicide transport lesions of the striatopallidal or striatonigral pathways on striatal ultrastructure.
    Roberts RC; Strain-Saloum C; Wiley RG
    Brain Res; 1995 Dec; 701(1-2):227-37. PubMed ID: 8925286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic treadmill exercise in rats delicately alters the Purkinje cell structure to improve motor performance and toxin resistance in the cerebellum.
    Huang TY; Lin LS; Cho KC; Chen SJ; Kuo YM; Yu L; Wu FS; Chuang JI; Chen HI; Jen CJ
    J Appl Physiol (1985); 2012 Sep; 113(6):889-95. PubMed ID: 22837167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin.
    Stirpe F; Wawrzynczak EJ; Brown AN; Knyba RE; Watson GJ; Barbieri L; Thorpe PE
    Br J Cancer; 1988 Nov; 58(5):558-61. PubMed ID: 3265330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal lesioning with axonally transported toxins.
    Wiley RG; Kline IV RH
    J Neurosci Methods; 2000 Nov; 103(1):73-82. PubMed ID: 11074097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting toxins to neural antigens and receptors.
    Wiley RG
    Methods Mol Biol; 2001; 166():267-76. PubMed ID: 11217372
    [No Abstract]   [Full Text] [Related]  

  • 27. 192IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei.
    Rossner S; Härtig W; Schliebs R; Brückner G; Brauer K; Perez-Polo JR; Wiley RG; Bigl V
    J Neurosci Res; 1995 Jun; 41(3):335-46. PubMed ID: 7563226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of p75 nerve growth factor receptor mRNA containing neurons in rat forebrain after intraventricular IgG 192-saporin administration.
    Singh V; Schweitzer JB
    Neurosci Lett; 1995 Jul; 194(1-2):117-20. PubMed ID: 7478191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
    Flavell DJ; Boehm DA; Noss A; Flavell SU
    Br J Cancer; 1997; 75(7):1035-43. PubMed ID: 9083340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility to seizure-induced injury and acquired microencephaly following intraventricular injection of saporin-conjugated 192 IgG in developing rat brain.
    Koh S; Santos TC; Cole AJ
    Exp Neurol; 2005 Aug; 194(2):457-66. PubMed ID: 16022871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin in rats.
    Wiley RG; Lappi DA
    Neurosci Lett; 1997 Jul; 230(2):97-100. PubMed ID: 9259473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons.
    Harrison MB; Wiley RG; Wooten GF
    Brain Res; 1992 Sep; 590(1-2):305-10. PubMed ID: 1422839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.
    Bergamaschi G; Perfetti V; Tonon L; Novella A; Lucotti C; Danova M; Glennie MJ; Merlini G; Cazzola M
    Br J Haematol; 1996 Jun; 93(4):789-94. PubMed ID: 8703804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraneural OX7-saporin for neuroma-in-continuity in a rat model.
    Mavrogenis AF; Pavlakis K; Stamatoukou A; Papagelopoulos PJ; Theoharis S; Zetahang Z; Soucacos PN; Zoubos AB
    Eur J Orthop Surg Traumatol; 2013 Apr; 23(3):263-72. PubMed ID: 23412299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective lesions of rabbit extraocular muscles injected with the anti-AChR immunotoxin saporin-mAb 73.
    Campos EC; Schiavi C; Bolognesi A; Bellusci C; Lubelli C; Duca A; Polito L; Poulas K; Tzartos SJ; Stirpe F
    Curr Eye Res; 2002 Jan; 24(1):58-65. PubMed ID: 12187496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys.
    Fine A; Hoyle C; Maclean CJ; Levatte TL; Baker HF; Ridley RM
    Neuroscience; 1997 Nov; 81(2):331-43. PubMed ID: 9300425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
    Flavell DJ; Flavell SU; Boehm DA; Emery L; Noss A; Ling NR; Richardson PR; Hardie D; Wright DH
    Br J Cancer; 1995 Dec; 72(6):1373-9. PubMed ID: 8519647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates.
    Siena S; Lappi DA; Bregni M; Formosa A; Villa S; Soria M; Bonadonna G; Gianni AM
    Blood; 1988 Aug; 72(2):756-65. PubMed ID: 3042047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective killing of CD4+ and CD8+ cells with immunotoxins containing saporin.
    Barbieri L; Bolognesi A; Dinota A; Lappi DA; Soria M; Tazzari PL; Stirpe F
    Scand J Immunol; 1989 Sep; 30(3):369-72. PubMed ID: 2571186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraseptal injection of the cholinergic immunotoxin 192-IgG saporin fails to disrupt latent inhibition in a conditioned taste aversion paradigm.
    Dougherty KD; Salat D; Walsh TJ
    Brain Res; 1996 Oct; 736(1-2):260-9. PubMed ID: 8930332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.